from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3903c/-

LFCtreatmentdescriptionclass of inhibitor

0.996

Amikacinug/mL Amikacintranslation

1.088

Cap5-10ug/mL Capreomycintranslation

2.020

Rox10-50 ug/mL Roxithromycintranslation

0.307

SM2-5 ug/mL Streptomycintranslation

2.655

Tet5-10 ug/mL Tetracyclinetranslation

0.843

Rif0.2-5ug/mL Rifampicintranscription

0.217

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.248

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.082

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.075

CPZ10-50 ug/mL Chlorpromazinerespiration

0.581

Clofazimine10-13 ug/mL Clofaziminerespiration

0.415

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.689

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.359

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.736

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.339

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.056

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.194

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.143

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.250

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.379

KCN5-20 ug/mL Potassium cyaniderespiration

-0.224

NaN30.2-2 mM Sodium aziderespiration

-0.157

Nigericin50 uM Nigericinrespiration

-0.512

TRC10-150 ug/mL Triclosanrespiration

1.998

TRZ10-25 ug/mL Thioridazinerespiration

2.799

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.189

menadione6-10 ug/mL Menadionerespiration

0.189

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.210

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.536

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.354

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.375

NRP_1Non-replicating persistence stage 1dosRassociated

-0.257

Amp0.2mg/mL AmpicillincellWall

-0.703

Cephalexin20-100 ug/mL CephalexincellWall

-0.053

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.248

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.447

EMB10-20 ug/mL EthambutolcellWall

-0.200

Eta12-40 ug/mL EthionamidecellWall

0.135

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.171

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.135

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.011

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.057

BZA0.12 mg/mL BenzamidearomaticAmides

-0.668

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.792

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.032

H2O24 mM hydrogen peroxideDNAdamaging

-0.354

Levo10 ug/mL LevofloxacinDNAdamaging

-0.757

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.392

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.438

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.356

UVUV-irradiationDNAdamaging

0.021

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.369

Antimycin12.5-50 ug/mL Antimycin A?

-0.181

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.775

PA_110-50 ug/mL Antitubercular compound PA-1?

0.518

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.125

PA8240.2-2 ug/mL PA-824?

0.968

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.073

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.151

Verapamil50 uM Verapamil?

-0.668

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.326

methoxatin10-20 ug/mL Methoxatin?